Cargando…
Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
BACKGROUND: Autoimmune retinopathy (AIR) is a rare but potentially blinding condition that is often underdiagnosed. Common features in AIR presentation include rapidly progressive vision loss with abnormal electrophysiological responses of the retina associated with positive anti-retinal antibodies....
Autores principales: | Boudreault, Katherine, Justus, Sally, Sengillo, Jesse D., Schuerch, Kaspar, Lee, Winston, Cabral, Thiago, Tsang, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512938/ https://www.ncbi.nlm.nih.gov/pubmed/28709429 http://dx.doi.org/10.1186/s13023-017-0680-7 |
Ejemplares similares
-
Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients
por: Sengillo, Jesse D., et al.
Publicado: (2017) -
Retrospective Analysis of Structural Disease Progression in Retinitis Pigmentosa Utilizing Multimodal Imaging
por: Cabral, Thiago, et al.
Publicado: (2017) -
Rituximab Monotherapy versus Rituximab and
Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
por: Maleki, Arash, et al.
Publicado: (2022) -
Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy
por: Maleki, Arash, et al.
Publicado: (2017) -
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
por: Sengillo, Jesse D., et al.
Publicado: (2017)